The nootropic supplement market is evolving as consumers demand greater transparency and convenience. OffScript has responded with the launch of two sublingual nootropic mints, FOCUS+FLOW and CALM+COLLECTED, formulated to support daily focus and stress resilience. The products are distinguished by their fully disclosed ingredient dosing, a departure from the proprietary blends common in the category.
Each mint lists every active ingredient with its exact dosage, allowing consumers to make informed decisions. The formulations include Citicoline, a choline precursor linked to cognitive function; Rhodiola Rosea, an adaptogen studied for fatigue and stress; and Ashwagandha, known for supporting cortisol regulation. FOCUS+FLOW targets cognitive clarity, while CALM+COLLECTED focuses on stress management.
The sublingual delivery method—absorption under the tongue—allows active compounds to enter the bloodstream more directly than traditional capsules or powders, offering faster onset. This format also provides portability, requiring no water or preparation, ideal for on-the-go use.
OffScript emphasizes third-party lab testing to verify potency and purity, positioning itself within the clean-label supplement movement. As scrutiny of supplement labeling grows, OffScript's approach of complete transparency and independent verification appeals to health-conscious consumers.
The launch comes at a time when the clean-label supplement space is expanding. OffScript's commitment to disclosed dosing and verified testing reflects a strategy centered on ingredient integrity. The products are available through OffScript's direct channels, extending the company's mission to provide nootropic solutions that align with informed health decisions.
